Refractory Acute Myeloïd Leukemia research hub

AML-NET : Acute Myeloid Leukemia treated with with NETrin Abs in combination with [AZACITIDINE + VENETOCLAX]

This study is looking at a new medicine called NETrin Abs, combined with two existing drugs, azacitidine and venetoclax. It's for people with a type of blood cancer called Acute Myeloid Leukaemia (AML) that hasn't responded to previous treatments.